Task: Answer the multiple-choice question.
Query: Which drug exhibits a 13.660\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CC(=O)c1cc(CCC(=O)NC2CCCCCC2)oc1C
b. COc1ccc2c(C)cc(SCC(=O)Nc3cccnc3Cl)nc2c1
c. O=C(NCc1ccccc1)C(c1ccco1)N(C(=O)c1ccccn1)c1ccccc1
Answer: b. COc1ccc2c(C)cc(SCC(=O)Nc3cccnc3Cl)nc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc2c(C)cc(SCC(=O)Nc3cccnc3Cl)nc2c1
COc1ccc2c(C)cc(SCC(=O)Nc3cccnc3Cl)nc2c1
N-(2-chloropyridin-3-yl)-2-(7-methoxy-4-methylquinolin-2-yl)sulfanylacetamide